Correction to “The anti-inflammatory and antiviral properties of anionic pulmonary surfactant phospholipids”

IF 7.5 2区医学 Q1 IMMUNOLOGY

Immunological Reviews Pub Date : 2024-03-21 DOI:10.1111/imr.13320

{"title":"Correction to “The anti-inflammatory and antiviral properties of anionic pulmonary surfactant phospholipids”","authors":"","doi":"10.1111/imr.13320","DOIUrl":null,"url":null,"abstract":"Numata M, Kandasamy P, Voelker DR. The anti-inflammatory and antiviral properties of anionic pulmonary surfactant phospholipids. Immunol Rev. 2023; 317: 166–186. doi:10.1111/imr.13207In the article, the second paragraph was inadvertently added to Summary section and should have been removed.The Summary reads:The minor anionic pulmonary surfactant phospholipids, POPG and PI, exhibit anti-inflammatory effects as antagonists for multiple TLRs. These lipids also have strong efficacies as antivirals against multiple respiratory RNA-enveloped viruses such as RSV, IAVs, and SARS-CoV-2. PI also has a potent effect against non-enveloped virus (human rhinovirus A). These lipids also have very strong potential to be applied as anti-inflammatory compounds for acute lung injury, induced by cytokine storms, including severe COVID-19.We determined the antiviral efficacy of POPG against five clinical isolates of RSV (designated by GenBank accession numbers) and recombinant strains of RSV (rA2-A2F, rA2-19F, and rA2 Long F) in comparison with RSV-A2.12 The titer of each strain is shown as PFU/mL, and the efficacies of POPG and POPC (200 μg/mL) on each strain are stated as the viral titers by plaque assays. Data are shown as means ± SD from two independent experiments.The Summary should read:The minor anionic pulmonary surfactant phospholipids, POPG and PI, exhibit anti-inflammatory effects as antagonists for multiple TLRs. These lipids also have strong efficacies as antivirals against multiple respiratory RNA-enveloped viruses such as RSV, IAVs, and SARS-CoV-2. PI also has a potent effect against non-enveloped virus (human rhinovirus A). These lipids also have very strong potential to be applied as anti-inflammatory compounds for acute lung injury, induced by cytokine storms, including severe COVID-19.We apologize for this error.","PeriodicalId":178,"journal":{"name":"Immunological Reviews","volume":"323 1","pages":"316"},"PeriodicalIF":7.5000,"publicationDate":"2024-03-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/imr.13320","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Immunological Reviews","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/imr.13320","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"IMMUNOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Numata M, Kandasamy P, Voelker DR. The anti-inflammatory and antiviral properties of anionic pulmonary surfactant phospholipids. Immunol Rev. 2023; 317: 166–186. doi:10.1111/imr.13207

In the article, the second paragraph was inadvertently added to Summary section and should have been removed.

The Summary reads:

The minor anionic pulmonary surfactant phospholipids, POPG and PI, exhibit anti-inflammatory effects as antagonists for multiple TLRs. These lipids also have strong efficacies as antivirals against multiple respiratory RNA-enveloped viruses such as RSV, IAVs, and SARS-CoV-2. PI also has a potent effect against non-enveloped virus (human rhinovirus A). These lipids also have very strong potential to be applied as anti-inflammatory compounds for acute lung injury, induced by cytokine storms, including severe COVID-19.

We determined the antiviral efficacy of POPG against five clinical isolates of RSV (designated by GenBank accession numbers) and recombinant strains of RSV (rA2-A2F, rA2-19F, and rA2 Long F) in comparison with RSV-A2.¹² The titer of each strain is shown as PFU/mL, and the efficacies of POPG and POPC (200 μg/mL) on each strain are stated as the viral titers by plaque assays. Data are shown as means ± SD from two independent experiments.

The Summary should read:

We apologize for this error.

查看原文本刊更多论文

更正 "阴离子肺表面活性物质磷脂的抗炎和抗病毒特性"。

Numata M, Kandasamy P, Voelker DR.阴离子肺表面活性磷脂的抗炎和抗病毒特性。Immunol Rev. 2023; 317: 166-186.doi:10.1111/imr.13207在文章中，摘要部分不慎添加了第二段，应予以删除。摘要如下：次要阴离子肺表面活性磷脂 POPG 和 PI 作为多种 TLR 的拮抗剂表现出抗炎作用。作为抗病毒药物，这些磷脂对多种呼吸道 RNA 病毒（如 RSV、IAV 和 SARS-CoV-2）也有很强的疗效。PI 对无包膜病毒（人鼻病毒 A）也有很强的抑制作用。这些脂质还具有很强的潜力，可用作细胞因子风暴（包括严重的 COVID-19）诱发的急性肺损伤的抗炎化合物。我们测定了 POPG 对五种 RSV 临床分离株（以 GenBank 编号命名）和 RSV 重组株（rA2-A2F、rA2-19F 和 rA2 Long F）的抗病毒效力，并与 RSV-A2 进行了比较12。每种毒株的滴度以 PFU/mL 表示，POPG 和 POPC（200 μg/mL）对每种毒株的效力以斑块检测的病毒滴度表示。数据以两个独立实验的平均值±标度表示。摘要应为：小阴离子肺表面活性磷脂 POPG 和 PI 作为多种 TLR 的拮抗剂，具有抗炎作用。作为抗病毒药物，这些磷脂对多种呼吸道 RNA 病毒（如 RSV、IAV 和 SARS-CoV-2）也有很强的疗效。PI 对无包膜病毒（人鼻病毒 A）也有很强的抑制作用。这些脂质还具有很强的潜力，可用作细胞因子风暴（包括严重的 COVID-19）诱发的急性肺损伤的抗炎化合物。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Immunological Reviews 医学-免疫学

CiteScore

16.20

自引率

1.10%

发文量

118

审稿时长

4-8 weeks

期刊介绍： Immunological Reviews is a specialized journal that focuses on various aspects of immunological research. It encompasses a wide range of topics, such as clinical immunology, experimental immunology, and investigations related to allergy and the immune system. The journal follows a unique approach where each volume is dedicated solely to a specific area of immunological research. However, collectively, these volumes aim to offer an extensive and up-to-date overview of the latest advancements in basic immunology and their practical implications in clinical settings.